News & Updates

More than half of NASH patients respond to HVPG-guided NSBB prophylaxis

30 Nov 2021

Hepatic venous pressure gradient (HVPG)-guided prophylaxis with non-selective beta blockers (NSBB) seems to be reasonably effective in patients with nonalcoholic steatohepatitis (NASH), eliciting responses from around half of this population, a recent study has found.

More than half of NASH patients respond to HVPG-guided NSBB prophylaxis

30 Nov 2021

Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor

30 Nov 2021 by

The glucagon-like peptide-1 receptor agonist (GLP-1 RA) efpeglenatide affords cardiovascular and renal protection that is not explained by concurrent use of a sodium-glucose co-transporter-2 (SGLT2) inhibitor in patients with type 2 diabetes (T2D), according to an exploratory analysis of AMPLITUDE-O.

Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor

30 Nov 2021

Childhood cancers often misdiagnosed as TB, leads to more deaths

30 Nov 2021

Cancer is frequently misdiagnosed as tuberculosis (TB) in children due to the clinical and radiologic overlap of the two diseases, which then contributes to increased mortality in this population, reveals a recent study.

Childhood cancers often misdiagnosed as TB, leads to more deaths

30 Nov 2021

New chest pain guideline: Takeaways & Concerns

30 Nov 2021 by

A new guideline on chest pain evaluation and diagnosis – touted as the first of its kind – is now out, reaping both praises and dissent from experts.

New chest pain guideline: Takeaways & Concerns

30 Nov 2021

Phase II data underscores lanifibranor potential for NASH

30 Nov 2021 by

In the phase IIb NATIVE* trial, the pan-PPAR** agonist lanifibranor demonstrated histologic benefits for patients with nonalcoholic steatohepatitis (NASH).

Phase II data underscores lanifibranor potential for NASH

30 Nov 2021

What is the optimal tanezumab dose, administration route for osteoarthritis pain?

30 Nov 2021

Intravenous treatment with tanezumab at 10 mg achieves the highest efficacy in terms of relieving pain in patients with osteoarthritis (OA), according to the results of a network meta-analysis.

What is the optimal tanezumab dose, administration route for osteoarthritis pain?

30 Nov 2021

Spontaneous eye blink rate a good marker of consciousness after brain injury

30 Nov 2021

In the postacute phase after brain injury, the spontaneous eye blink rate is higher in patients in a minimally conscious state and may help distinguish MCS from the vegetative state/unresponsive wakefulness syndrome, a recent study has found.

Spontaneous eye blink rate a good marker of consciousness after brain injury

30 Nov 2021

High vegetable and fruit intake improves QoL among Chinese breast cancer patients

30 Nov 2021 by

High consumption of vegetables and fruits is found to be positively associated with quality of life (QoL), cognitive, physical and emotional functioning, as well as less severe symptoms of nausea, vomiting, dyspnoea, diarrhoea, loss of appetite, insomnia and constipation in Chinese women with early-stage breast cancer, researchers at the Chinese University of Hong Kong (CUHK) and Princess Margaret Hospital (PMH) have reported.

High vegetable and fruit intake improves QoL among Chinese breast cancer patients

30 Nov 2021

CONUT, PNI predict technique failure during peritoneal dialysis

29 Nov 2021

In patients undergoing peritoneal dialysis (PD), the Controlling Nutritional Status (CONUT) score and Prognostic Nutritional Index (PNI) seem to be independent predictors of technique failure (TF), a recent study has found.

CONUT, PNI predict technique failure during peritoneal dialysis

29 Nov 2021

Higher sodium, lower potassium urine excretion tied to increased CV risk

29 Nov 2021 by

Higher sodium and lower potassium intake, measured through repeat 24-hour urine samples, are tied to an elevated risk of cardiovascular (CV) events, according to a study presented at AHA 2021.

Higher sodium, lower potassium urine excretion tied to increased CV risk

29 Nov 2021

News & Updates

Filter by Specialty:

Specialty:

More than half of NASH patients respond to HVPG-guided NSBB prophylaxis

More than half of NASH patients respond to HVPG-guided NSBB prophylaxis

Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor

Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor

Childhood cancers often misdiagnosed as TB, leads to more deaths

Childhood cancers often misdiagnosed as TB, leads to more deaths

New chest pain guideline: Takeaways & Concerns

New chest pain guideline: Takeaways & Concerns

Phase II data underscores lanifibranor potential for NASH

Phase II data underscores lanifibranor potential for NASH

What is the optimal tanezumab dose, administration route for osteoarthritis pain?

What is the optimal tanezumab dose, administration route for osteoarthritis pain?

Spontaneous eye blink rate a good marker of consciousness after brain injury

Spontaneous eye blink rate a good marker of consciousness after brain injury

High vegetable and fruit intake improves QoL among Chinese breast cancer patients

High vegetable and fruit intake improves QoL among Chinese breast cancer patients

CONUT, PNI predict technique failure during peritoneal dialysis

CONUT, PNI predict technique failure during peritoneal dialysis

Higher sodium, lower potassium urine excretion tied to increased CV risk

Higher sodium, lower potassium urine excretion tied to increased CV risk